INTRODUCTION
Aspergillus fumigatus, an opportunistic lung pathogen, is the main aetiological agent of human aspergillosis. The increasing incidence of both allergic aspergillosis and fatal invasive aspergillosis, and the limited success of currently available therapy, has prompted the search for novel therapeutic strategies. Adhesion of inhaled airborne A. fumigatus conidia to the host lung epithelial cells and extracellular matrix (ECM) components is thought to be one of the primary steps for initiation of infection (Annaix et al., 1992) . Lungs with damaged epithelial lining and exposed ECM are more susceptible to infection by A. fumigatus (Bodey & Vartivarian, 1989; Coulot et al., 1994) .
ECM proteins of the host, namely fibronectin, laminin, collagens and proteoglycans, are implicated in attachment of a number of fungal pathogens (Gaur & Klotz, 1997; Gil et al., 1996; Gonzalez et al., 2005; Lopez-Ribot & Chaffin, 1994; Mendes-Giannini et al., 2006; Tronchin et al., 1997; Wasylnka & Moore, 2000) . Adhesion of A. fumigatus conidia to fibrinogen is mediated by the D domain of fibrinogen (Annaix et al., 1992) , and increases with the maturation of conidia (Coulot et al., 1994) .
Adherence is indicative that the fungal factors recognize ligands (protein or carbohydrate) on the surface of host cells or constituent(s) of the ECM. These pathogen factors, with an affinity towards ECM component(s), are envisaged to contribute to the virulence. Several studies have implicated cell wall proteins or carbohydrates of A. fumigatus as being adhesins, and characterized their interactions with ECM components (Annaix et al., 1992; Bouchara et al., 1997; Penalver et al., 1996; Thau et al., 1994) . Sturtevant & Latge (1992) identified a 54-58 kDa conidial surface protein that binds human complement component C3 and/or a C3 fragment. Two polypeptides, with molecular masses of 23 and 30 kDa, present in whole conidial homogenate and 2-mercaptoethanol extract from isolated conidial cell walls, respectively, are reported to specifically interact with fibronectin (Penalver et al., 1996) . Interaction of A. fumigatus conidia with laminin has been shown to be mediated by a 72 kDa laminin-binding protein expressed at the cell wall surface of resting conidia (Tronchin et al., 1997) . Gil et al. (1996) identified one polypeptide with an apparent molecular mass of 37 kDa from whole conidial homogenates that specifically interacts with laminin. The rodletless mutant of A. fumigatus displayed reduced collagen affinity, but retained affinity with pneumocytes, fibrinogen and laminin (Thau et al., 1994) .
In view of the multifactorial nature of conidial adhesion, the relevance of the adhesins for understanding pathogenesis and the plausible application of anti-adhesins for the prevention and therapy of aspergillosis, we attempted global screening of the A. fumigatus proteome to identify putative adhesins using a bioinformatics-based approach.
METHODS

Bioinformatic analysis
Prediction of adhesion proteins of A. fumigatus using an in silico approach. SPAAN, a software program for amino acid sequence based prediction of adhesins and adhesin-like proteins, was used for the prediction of potential adhesins in the A. fumigatus proteome. Sequences of A. fumigatus proteins were downloaded from the website of the Institute of Genomic Research (http://www.tigr.org/tdb/e2k1/afu1/).
Amino acid sequence analysis of AfCalAp. PSORT II (http:// psort.nibb.ac.jp/form2.html) and SignalP 3.0 (http://www.cbs.dtu. dk/services/SignalP/) were used to determine the cellular localization and to identify the signal peptide of AfCalAp, respectively. The thaumatin domain was identified using InterProScan software (http:// www.ebi.ac.uk/Tools/InterProScan/). Sequence alignment of AfCalAp with two previously known thaumatin consensus containing proteins was carried out using Muscle software (http://www.ebi.ac.uk/Tools/ muscle/index.html).
A. fumigatus strain. A. fumigatus strain Af293, isolated from the lungs of an invasive aspergillosis patient, was kindly provided by Dr D. W. Denning (School of Medicine, University of Manchester, Manchester, UK). This is the same strain that was used in the past for the whole genome sequencing project by the Sanger Institute (Hinxton, Cambridge, UK) and the Institute of Genomic Research (TIGR, Rockville, MD, USA).
Isolation of A. fumigatus conidia. A. fumigatus was freshly subcultured on Sabouraud dextrose agar (Himedia). Conidia were harvested after 72 h growth, using PBS and were pelleted by centrifugation at 12 000 g for 10 min at 4 uC. The conidial pellet was washed twice with PBS and stored in fresh PBS at 4 uC until use. Before use in experiments, the pellet was resuspended in fresh PBS and an aliquot of the conidia (i.e. resting conidia) was further diluted and quantified using a haemocytometer to count the number of colony forming units.
Incubation of conidia with lung epithelial cell line (A549)-derived ECM. The A549 matrix was generated as described by Bromley & Donaldson (1996) with some modifications. Monolayers of A549 lung epithelial cell line (procured from the National Centre for Cell Science, Pune, India) were prepared in the cell culture flasks. To remove cells from the matrix, the confluent cell layer was washed with sterile PBS and incubated with 0.1 % sodium azide for 90 min. This treatment was followed by an incubation with 4 % sodium deoxycholate and 0.1 % sodium azide for 1 h at room temperature. The flasks were washed twice with PBS, 0.05% Tween 20, followed by a wash with PBS, and the surface was microscopically examined to ensure removal of the cells. The presence of ECM on the flask surface was confirmed using Bradford reagent (Sigma) for protein estimation (Bradford, 1976) .
A total of 2610 9 A. fumigatus conidia were suspended in 30 ml RPMI 1640 medium (Sigma) and incubated in the culture flask containing the A549-derived ECM (1 h swollen conidia with ECM), whereas, in the control flask, conidia were incubated with RPMI 1640 medium (1 h swollen conidia) at 37 uC for 1 h. The medium was then aspirated and replaced with ice-cold Dulbecco's PBS. The conidia adhered to the culture flasks were dislodged using a cell scraper and were pelleted at 14 000 g for 5 min at 4 uC. These conidial pellets were quickly frozen using liquid nitrogen and used for RNA isolation. For examining the conidial surface reactivity of anti-AfCalAp serum, conidia obtained after 2 h incubation with RPMI 1640 (2 h swollen conidia) were suspended in Dulbecco's PBS and subjected to a further step (endogenous peroxidase inactivation).
Isolation of total RNA from conidia. Frozen conidial pellets were ground to a fine powder in the presence of liquid nitrogen using a mortar and pestle. Total RNA was isolated using an EZ-RNA isolation kit (Biological Industries), DNase treated and the RNA cleaned using the RNeasy mini protocol (Qiagen). The quality of total RNA was confirmed by assessing the A 260 /A 280 ratio and looking for prominent intact 26S and 18S ribosomal bands without any genomic DNA contamination by gel electrophoresis.
RT-PCR. First strand cDNA synthesis from the fungal RNAs was achieved using M-MuLV reverse transcriptase (New England Biolabs) as per the manufacturer's protocol. The enzyme was inactivated at 90 uC for 10 min. These cDNAs were used as templates in PCRs using gene-specific primers designed with the help of PrimerSelect software (DNASTAR). AfCalA-specific forward and reverse primers contained BamHI and XhoI restriction endonuclease sites, respectively, as underlined in the following primer sequences: Fp559-GGATCC-ACATGATGTTCACCAAG-39 and Rp559-CTCGAGCTAGTTGCC-AATGTTC-39. Primers for Actin were designed to target an exonexon boundary so as to give multiple amplification products in case of any genomic DNA contamination in cDNA (data not shown). The sequences of these primers were as follows: Fp559-AACTTCCCG-ATGGTCAGGTCA-39, Rp559-AGAGGCCAGAATGGAACCAC-39.
Cloning, expression and purification of AfCalAp. The DH5a strain of Escherichia coli was used for cloning. Gel-purified PCR product was cloned in pGEMT-easy vector (Promega) using the manufacturer's protocol. The insert was cleaved out of the pGEMTeasy vector by BamHI/XhoI digestion and was cloned into pGEX-5X23 vector between the BamHI and XhoI sites. Cloning and gene identity were confirmed by restriction digestion and by sequencing of the cloned insert, respectively. For expression, the plasmid was used to transform the BL-21 strain of E. coli. Recombinant protein expression was induced with the addition of 0.2 mM IPTG to the exponential phase bacterial culture (OD 600 50.6) and growth for 4 h at 30 uC in Luria broth. The recombinant protein was purified by glutathione affinity chromatography as described previously (Saxena et al., 2003) . Expressed glutathione S-transferase (GST) fusion protein, as visualized using SDS-PAGE, showed an approximate molecular mass of 45 kDa (Fig. 1) 
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. In view of the low yield of protein, induction of the bacterial culture was done at a large scale to get a sufficient amount of recombinant protein for further studies. Purified protein was dialysed to remove DTT and glutathione using dialysis membrane with a 12 kDa cut-off (Sigma). The GST-tagged fusion protein was subjected to factor Xa (Qiagen) cleavage using the manufacturer's protocol, followed by SDS-PAGE. The AfCalAp band was excised from the gel and the purified recombinant protein was obtained by electroelution for use in immunological characterization and production of anti-AfCalAp serum. Recombinant L3 ribosomal protein of A. fumigatus, used as a control during the study, was expressed and purified as described previously (Saxena et al., 2003) .
Raising polyclonal anti-AfCalAp in mice. With an approved protocol from the Institute of Genomics and Integrative Biology animal ethics committee, specific-pathogen-free 4-to 6-week-old BALB/c mice were obtained from the animal house facility of the National Institute of Immunology (New Delhi, India), and were intraperitoneally immunized with 25 mg recombinant AfCalAp in 100 ml PBS (pH 7.4) and 100 ml Freund's complete adjuvant (Sigma). At 2 and 4 weeks following the primary immunization, intraperitoneal booster immunizations were performed with 25 mg protein in Freund's incomplete adjuvant (Sigma). Control mice were immunized with the adjuvant and PBS. All the mice were sacrificed 2 weeks after the second booster immunization and sera collected. The titre of the anti-AfCalAp serum was evaluated by its immunoreactivity with recombinant AfCalAp on the dot-blots.
Expression of AfCalAp on the conidial surface ELISA. The 2 h swollen conidia (2610 8 per well in a 96-well culture plate) were incubated with Dulbecco's PBS containing 1 % (v/v) H 2 O 2 for 15 min to block the endogenous peroxidase reactivity. After washing, the conidia were incubated overnight at 4 uC in Dulbecco's PBS (Himedia). Unbound conidia were removed by washing twice with Dulbecco's PBS. Control or anti-AfCalAp mouse sera were diluted 1 : 50 in Dulbecco's PBS containing 1.5 % BSA and were added to separate wells. After incubation at 37 uC for 1 h, the wells were washed twice with Dulbecco's PBS and incubated for 2 h with protein A-horseradish peroxidase conjugate (Bangalore Genei) diluted 1 : 750 in Dulbecco's PBS containing 1.5 % BSA. After washing once with PBS, 0.05% Tween 20, and twice with PBS, AfCalAp expression on conidia was detected using chromogen ortho-phenyldiamine and H 2 O 2 as substrate. The reaction was stopped using 4 M H 2 SO 4 and the absorbance was read at 492 nm.
Immunofluorescence (laser scanning) microscopy. The 2 h swollen conidia (10 7 cells) were fixed in 100 ml 4 % paraformaldehyde in PBS at room temperature for 20 min. They were smeared on poly-L-lysine (Sigma) coated clean glass slides and left to air dry for 10 min. Nonspecific interactions were blocked using 5 % normal goat serum (blocking solution) (Bangalore Genei) for 45 min at room temperature in a moist chamber. Slides were incubated overnight with mice sera (anti-AfCalAp or control) at 1 : 50 dilution in blocking solution at 4 uC. After three washes with PBS, the smears were incubated with phycoerythrin-labelled anti-mouse IgG raised in goat (Sigma) for 1 h at room temperature in moist conditions. After three washes, the slides were counterstained with DAPI (4',6-diamidino-29-phenylindole dihydrochloride) (Roche Diagnostics) and mounted in Vectashield (Vector Laboratories). Serial sections of the fluorescent cells were obtained with a Zeiss LSM 510 meta laser scanning confocal microscope, using a 488 argon ion laser (Carl Zeiss). The gain settings etc. were optimized for each image. Serial sections (xy plane) were obtained at 0.5 mm intervals for conidia. Three-dimensional reconstructions were obtained by the resident software.
Interaction of AfCalAp with murine lung and spleen cell suspension
Preparation of murine lung and spleen cell suspension. Lung and spleen tissues from naive BALB/c mice were minced in the presence of ice-cold Dulbecco's PBS (Himedia) between slides with a frosted surface. A sterile nylon mesh was used to remove the tissue debris. Red blood cells were removed by incubating the cell suspension with red blood cell lysis buffer (1.04 g NH 4 Cl, 0.125 g NaHCO 3 and 0.01 g EDTA in 50 ml MilliQ water) for 5 min at room temperature. After two washes in Dulbecco's PBS, the cells were suspended in ice-cold FACS buffer (0.5 % BSA, 0.1 % sodium azide in Dulbecco's PBS). Microscopic examination confirmed that these were single cell suspensions. The number of cells was counted on a haemocytometer.
Fluorescein isothiocyanate (FITC)-labelling of AfCalAp-GST and
GST. Recombinant AfCalAp-GST and GST were labelled with FITC (Sigma) using a protocol described by Holmes & Fowlkes (1996) . Flow cytometry. Lung or spleen cell suspensions (300 ml 7.5610 5 cells ml 21 in FACS buffer) were incubated with 9 mg FITC-labelled AfCalAp or equivalent moles of FITC-labelled GST for 45 min at 4 uC. After three washes with FACS buffer, the cells were fixed in 4 % formaldehyde in PBS. Five-thousand cells from each sample were assayed using an EasyCyte plus flow cytometry system (Guava Technologies). WinMDI version 2.8 was used for analysis of flowcytometry data. The number of cells with associated FITC fluorescence was used as a measure of the labelled AfCalAp protein binding to lung/spleen cells. protein (BSA; Sigma) was spotted on nitrocellulose membranes. After blocking with 3 % skimmed milk powder, the dot-blot membranes were incubated with AfCalAp-GST (40 mg protein diluted in 2.5 ml tris-buffered saline, 0.05% Tween 20 (TBST), containing 3 % skimmed milk powder) or equal amounts of GST on a shaker for 3 h at 37 uC. After two TBST washes, the membranes were incubated with anti-GST peroxidase (Promega; 1 : 2000 diluted in TBST containing 3 % skimmed milk powder) for 3 h at 37 uC. Membranes were washed twice with and once with tris-buffered saline (TBS) and the reaction was detected by 3, 39 diaminobenzidine and hydrogen peroxide.
Interaction of AfCalAp with laminin. A total of 2 mg per well (Maxisorp; Nunc) of laminin in PBS (0.02 mg ml 21 ) was incubated overnight at 4 uC. After blocking the samples in the wells with 3 % skimmed milk powder, 1 mg each of test (AfCalAp) or control (L3 ribosomal protein) proteins were added to different wells and incubated for 2 h at 37 uC. In the binding inhibition experiments, AfCalAp was mixed with various dilutions of anti-AfCalAp serum before its addition to different wells. Anti-GST peroxidase (Promega; 1 : 2000 diluted in PBS containing 3 % skimmed milk powder) was added and binding of AfCalAp was probed using chromogen orthophenyldiamine and H 2 O 2 .
Human sera. Following the guidelines of the Institute of Genomics and Integrative Biology ethics committee, the patients' sera (n57) used in the study were obtained from clinically confirmed cases of allergic bronchopulmonary aspergillosis (ABPA) [satisfying Rosenberg's criteria (Rosenberg et al., 1977) ] registered at the V. Patel Chest Institute, Delhi, India. Sera obtained from healthy, consenting donors (n57) with no history of pulmonary disease were used as controls.
IgG and IgE antibodies specific to AfCalAp in the sera of ABPA patients. A total of 2 ml electroeluted GST-tag less AfCalAp (1 mg ml 21 ) was spotted onto nitrocellulose membrane. To determine the IgG and IgE reactivity of AfCalAp, the dot-blots containing AfCalAp spots were incubated with patient/control serum (1 : 100 diluted in TBST for IgG reactivity and 1 : 20 diluted in TBST for IgE reactivity). Binding of IgG and IgE antibodies was probed using protein Ahorseradish peroxidase conjugate (1 : 750 diluted in TBST containing 3 % skimmed milk powder) and anti-IgE-horseradish peroxidase conjugate (1 : 750 diluted in TBST containing 3 % skimmed milk powder), respectively. Membranes were washed and the reaction was detected as described above.
RESULTS AND DISCUSSION
The current study presents a bioinformatics-based approach for the identification of adhesion proteins in A. fumigatus and other fungi, and validates the approach by characterizing the adhesin nature of recombinant extracellular thaumatin domain protein (AfCalAp) of A. fumigatus, predicted as a potential adhesin by SPAAN software.
Bioinformatic analysis of AfCalAp
To identify novel adhesion proteins (adhesins) of A. fumigatus, we screened its proteome in silico using SPAAN. This software was developed by employing 105 compositional properties and artificial neural networks, and has been validated for the prediction of bacterial adhesins (Sachdeva et al., 2005) . SPAAN had an optimal sensitivity of 89 % and specificity of 100 % on a defined test set, and could identify 97.4 % of known adhesins at a high P ad (probability of being adhesin) value from a wide range of bacteria. As the adhesins used for training this program belonged to microbes from diverse classes of organisms and one third (approx.) of non-adhesins employed for this purpose were from Saccharomyces cerevisiae, we envisaged SPAAN to be useful for the prediction of fungal adhesins. Among 9894 proteins screened, 0.83 % (n582) had a P ad value .0.9 (25 of them are listed in Table 1 ), 2.47 % (n5243) proteins had a P ad value .0.8, whereas, those having a P ad value .0.5 constituted 11.62 % (n51149) of the proteome. The mean P ad value per protein was 0.274. RodA hydrophobin, known to have a role in the adhesion of A. fumigatus, was assigned with a P ad value of 0.79. In view of its good adhesion potential (P ad .0.9), its small ORF size (534 bp) facilitating cloning/expression and an earlier study describing its presence on the fungal cell wall (Belaish et al., 2008) , we selected AfCalAp (Afu3g09690) for further in vitro studies. Serine, threonine and proline were found to constitute 24.89 % of the total amino acids in the sequence of AfCalAp, i.e. a characteristic typical of adhesins (Levdansky et al., 2007) . SPAAN assigned a P ad value of 0.942171 to AfCalAp, whereas, L3 ribosomal protein (Afu2g11850) was assigned a comparatively low P ad value of 0.1891, and was used as a control protein in the characterization experiments.
AfCalAp was predicted as a cell wall or extracellular protein by the PSORT II program. The ORF of AfCalA is 534 bp, coding for a protein of 177 amino acids with an approximate molecular mass of 18.7 kDa and pI of 4.2 (as estimated using the EDITSEQ program of DNASTAR). SignalP 3.0 identified a signal peptide spanning amino acids 1-18 (Supplementary Fig. S1 available with the online journal). The thaumatin consensus was found to be localized between amino acids 73 and165 of AfCalAp by InterProScan.
Recent observations show that several of the plant thaumatin-like proteins bind and hydrolyse 1,3-b-glucans of the type commonly found in fungal cell walls (Osmond et al., 2001; Trudel et al., 1998) . Thaumatin-like proteins from several basidiomycete fungi exhibited 1,3-b-glucanase activity (Osmond et al., 2001; Trudel et al., 1998) . Their biological role in fungi is under investigation. To compare its sequence with previously known thaumatin consensus containing proteins, AfCalAp was aligned with PR-5d, an antifungal thaumatin domain protein from Nicotiana tobacum [identity518.0 %, positives (amino acids replaced by amino acids of a similar nature)515.3 %] and sweet tasting thaumatin domain protein, thaumatin A, from Thaumatococcus daniellii (identity517.6 %, positives5 14.0 %). No significant homology between AfCalAp and these proteins could be detected and amino acid residues crucial for imparting antifungal activity or sweet taste to different thaumatin domain proteins were found to be absent (Koiwa et al., 1999) (Supplementary Fig. S1 available with the online journal). Disruption of CetA and CalA (CetA/CalA double mutant), AfCalA homologues in Aspergillus nidulans (E-values for protein-2 BLAST with AfCalAp are 3e 260 and 6e
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, respectively), showed a synthetic lethal phenotype, with most of its conidia completely inhibited in germination (Belaish et al., 2008) .
AfCalA transcripts detected in 1 h swollen A. fumigatus conidia We reasoned that adhesion-related genes might be upregulated in the presence of host ECM. To test this hypothesis, we examined the relative expression of AfCalA in 1 h swollen conidia in the presence and absence of A549-derived ECM. RT-PCR of AfCalA and Actin was carried out using RNA isolated from resting A. fumigatus conidia and conidia incubated for 1 h with RPMI 1640 medium in the presence and absence of A549 cell linederived ECM. In contrast to Actin, expression of AfCalA was not detected in resting conidia (data not shown). In conidia incubated for 1 h with RPMI 1640 medium, AfCalA and Actin did not show any variation in transcript levels in the presence or absence of A549-derived ECM ( Supplementary Fig. S2 available with the online journal). The identity of the AfCalA and Actin transcripts was confirmed by agarose gel electrophoresis in parallel with DNA ladders and by sequencing the PCR products. Greenstein et al. (2006) have also made similar observations for AfCalA and AnCalA, wherein transcripts for both the genes were detectable exclusively in early germinating conidia (1 and 2 h swollen conidia). In Candida albicans, expression of adhesins has been found to be modulated under different host and model conditions (Green et al., 2004; Cheng et al., 2005) . However, no significant modulation could be detected in the transcript expression of AfCalA in response to exposure of conidia to A549-derived ECM in comparison with the control. The conidial transcriptome, however, has been found to undergo modulation under these conditions (S. K. Upadhyay, Y. Singh, S. F. Basir & T. Madan unpublished). AfCalA expression seems to be linked to the germination process and may not be dependent on the presence of host ECM.
Anti-AfCalAp antibodies significantly bound to A. fumigatus conidia
The binding of anti-AfCalAp serum to 2 h swollen conidia was found to be significantly greater (P ,0.05) in comparison to control serum (Fig. 2) . Anti-AfCalAp serum also showed significant binding to resting conidia but it was lesser than the binding of anti-AfCalAp serum to 2 h swollen conidia (Fig. 2) .
We examined the binding of anti-AfCalAp to the surface of resting and swollen conidia by immunofluorescence confocal microscopy (Fig. 3a, b, c, d , e, f). Serial sections and three-dimensional reconstructions of resting and 2 h swollen conidia (Fig. 3b, c) probed with anti-AfCalAp, also revealed the presence of AfCalAp on the conidial surface. Gil et al. (1996) have already shown the binding of laminin to the surface of resting and swollen conidia using fluorescence confocal microscopy. Proteinaceous molecule(s) on the surface of conidia has/have been suggested to be responsible for their laminin affinity and a 37 kDa protein in the conidial extract has been shown to bind to laminin. No laminin binding was observed on the hyphal surface. We have not examined the reactivity of antiAfCalAp with hyphae of A. fumigatus; however, Greenstein et al. (2006) have described the absence of AfCalA transcripts in the hyphae.
As the conditions used for interaction did not allow permeabilization of the conidia by anti-AfCalAp, the above data suggest the presence of AfCalAp on the surface of conidia. AfCalAp showed high homology and a similar expression pattern to AnCalA, its homologue (E-value56e
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, identity542 %, positives556 %) in A. nidulans (Greenstein et al., 2006) , which has been shown to be localized on cell wall in geminating (8 h) conidia (Belaish et al., 2008) .
Similar to AnCalA, AfCalAp possesses an 18-residue Nterminal signal sequence (as identified using SignalP 3.0). The presence of the signal peptide suggests AfCalAp is a secreted protein. Furthermore, we found reactivity of the anti-AfCalAp serum with a third week culture filtrate of A. fumigatus (data not shown).AfCalAp on the cell wall might be predicted to be present only during transit; however, this does not abrogate the adhesin characteristics of AfCalAp, as to the function as an adhesin, the protein need not necessarily be permanently present on the cell surface (Klein, 2000) . The WI-1 adhesin of Blastomyces dermatitidis is secreted in the extracellular space and is present on the cell wall as well. It has been proposed that this WI-1 adhesin achieves a cell wall localization postsecretion by forming disulfide bridges with covalently attached cell wall proteins and by binding non-covalently to chitin fibrils (Brandhorst & Klein, 2000) . The presence of multiple cysteine residues in AfCalAp may facilitate a disulfide-bond-based anchorage of AfCalAp on the A. fumigatus cell wall, as proposed for WI-1 adhesin. Noncovalent interactions may also play a role in the cell wall localization of AfCalAp, as numerous thaumatin domain proteins have been shown to bind b-glucan in the fungal cell walls (Osmond et al., 2001; Trudel et al., 1998) .
A significantly higher immunoreactivity of the 2 h swollen A. fumigatus conidia than the resting conidia with antiAfCalAp serum was revealed by ELISA, corroborates our RT-PCR results, wherein AfCalA transcripts were detected only in the swollen conidia and were absent in the resting conidia. The increased immunoreactivity of swollen conidia towards anti-AfCalAp serum thus seems to be an outcome of increased expression of AfCalA during the early stage of germination. However, immunofluorescent staining does not clearly show a higher level of staining in the 2 h swollen conidia. This may be because the swollen conidia are larger and the binding is distributed less densely. AfCalAp has sequence homology with a putative glycosylphosphatidylinositol (GPI)-anchored cell wall protein (Afu3g00510, E-value54e 236 ), a Bys1 family protein (Afu2g04533, E-value55e 204 ) and BYS1 domain protein (Afu5g01990, E-value51e 207 ) of A. fumigatus, with predicted cell wall (or extracellular, as predicted using PSORT II) localization (data not shown). It is plausible that the presence of AfCalAp homologues on the conidial surface may also contribute to the anti-AfCalAp serum reactivity of resting A. fumigatus conidia. However, the presence of AfCalAp on resting conidia, as a carried over translation product from their parent conidiating hyphae, cannot be ruled out and needs further investigation.
AfCalAp interaction with laminin
Dot-blots showed significant binding of AfCalAp with laminin in comparison with the control protein (BSA) or other ECM components (Fig. 4a) . ELISA results with laminin-coated plates were in concordance with the dotblot results (Fig. 4b) . Furthermore, as revealed by an ELISA-based inhibition assay, laminin binding of AfCalAp was inhibited in a dose-dependent manner in the presence of anti-AfCalAp serum (Table 2) .
Laminin receptors have been detected as being distributed uniformly on the surface of A. fumigatus conidia and a 72 kDa protein was identified as reacting specifically with laminin (Tronchin et al., 1997) . Thus, it is plausible that along with the 72 kDa laminin-binding protein, AfCalAp also contributes to the laminin binding of A. fumigatus conidia.
AfCalAp binding to murine lung and spleen cells
Flow-cytometry data showed significantly higher affinity of murine lung cells towards AfCalAp in comparison with the control protein (Fig. 5a, b, c, d ). Furthermore, AfCalAp showed higher binding with the lung cells in comparison to spleen cells (Fig. 5d ).
The binding of recombinant AfCalAp to the murine lung and spleen cells suggests its relevance in the adhesion of fungal conidia to host cells. Earlier studies have shown the binding of A. fumigatus conidia to pulmonary epithelial cells. Lung epithelial cells have been shown to express receptors in response to stimulation by gamma interferon, leading to their increased avidity to A. fumigatus conidia (Bromley & Donaldson, 1996) . Variable expression of such receptor molecules on lung/spleen cells could explain the higher affinity of lung cell suspension than splenic cell suspension. These receptor molecules might be able to bind AfCalAp directly or through the affinity held laminin molecules. It would be worthwhile to identify the AfCalAp receptors on host cells.
Detection of IgG and IgE antibodies to AfCalAp in the sera of ABPA patients
The immunoreactivity of AfCalAp was examined using serum from seven ABPA patients and seven healthy controls. Serum from four of the ABPA patients showed IgG reactivity towards AfCalAp, whereas only two of the ABPA patients showed IgE reactivity towards AfCalAp. None of the healthy controls showed the presence of IgG or IgE antibodies to AfCalAp (Fig. 6) . These results were further confirmed by ELISA (data not shown).
The host generates antibodies to pathogenic proteins. Hence, we examined AfCalAp-specific IgG and IgE antibodies in the sera of ABPA patients. The presence of (Krebitz et al., 2003) .
Antibodies against adhesins have been shown to be effective in the inhibition of microbial adhesion to host surfaces and have been proposed as an effective therapeutic strategy (Chaturvedi et al., 2005; Masuoka et al., 1999) . Anti-AfCalAp significantly inhibited the interaction of laminin with AfCalAp, suggesting that specific AfCalAp antibodies could be useful for the prevention and therapy of aspergillosis. P4  P5  P6  P7   C1  C2  C3  C4  C5  C6  C7   P1  P2  P3  P4  P5  P6  P7   C1  C2  C3  C4  C5  C6  C7 Control serum ABPA serum Control serum Fig. 6 . Immunoreactivity of AfCalAp determined by dot-blot using diluted serum from ABPA patients (P1-P7) and healthy controls (C1-C7). (a) IgG reactivity of ABPA patients and healthy controls examined using 1 : 100 diluted serum, (b) IgE reactivity of ABPA patients and healthy controls examined using 1 : 20 diluted serum. The experiment was repeated three times with the same results.
